What's driving Dialysis Market ; Eminent Players - Asahi Kasei Corporation, B. Braun Melsungen, Baxter International, Fresenius Medical Care, JMS, Kawasumi Laboratories, Medtronic, Nikkiso, Nipro, Toray, DaVita, U.S. Renal Care, Satellite Healthcare and R

Dialysis Market will exceed USD 104 billion by 2024; as per a new research report. Increasing prevalence of renal diseases in developed as well as developing countries will drive the dialysis market growth over the forecast period. According to the National Kidney Foundation 2015 data, around 10% of the population worldwide is suffering from chronic kidney diseases. Shortage of kidney donors worldwide will surge the demand for dialysis treatment thereby positively influencing the industry growth.

Growing geriatric population base prone to various chronic diseases will augment industry growth. Adoption of peritoneal dialysis among elderly patient base is increasing in recent years owing to its benefits over hemodialysis. Furthermore, increasing healthcare expenditure and presence of advanced healthcare facilities will further spur business growth during the analysis timeframe.

Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/3001

Growing R&D investment to develop superior quality dialysis devices will render positive impact on dialysis market. Moreover, favorable reimbursement scenario for dialysis treatment in developed economies will further accelerate industry growth. However, high cost of dialysis treatment may hamper business growth, especially in the developing economies. Complications associated with the dialysis procedure including defects in devices or dialysis system may further restrain industry growth to certain extent.

Peritoneal dialysis segment accounted for USD 7.8 billion in 2017 and is estimated to show considerable growth over forecast period. The growth is attributable to ever-increasing burden of kidney diseases across the globe. Peritoneal dialysis treatment is less invasive and easy to perform and hence preferred by a large patient population. Furthermore, availability of subsidies to peritoneal dialysis beneficiaries should further increase its adoption over the coming years.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/3001

Equipment segment will experience 4.3% CAGR by 2024 and segmental growth will be attributed to growing preference for equipment utilized in dialysis treatment. Dialysis machines utilized in hemodialysis and peritoneal dialysis treatment need replacement since machines get damaged and require replacement to aid accurate diagnosis thus, will augment business growth.

Home dialysis segment accounted for over 29% revenue share in 2017 due to rapidly growing elderly population base worldwide. Benefits offered by home dialysis treatment such as flexible schedule, personal control, less medications as well as lesser and shorter hospital stays will spur segmental growth. Growing inclination of patients towards home dialysis owing to its convenience should upsurge the dialysis market growth over the coming years.

U.S. dialysis market will grow at 3.9% during the forecast timeline owing to technological advancement. Moreover, availability of advanced healthcare infrastructure and increasing prevalence of renal diseases further boosts business growth in the country. As per the U.S. Renal Data System Annual Data Report in 2015, over 660,000 Americans were affected by kidney failure or end stage renal disease. Growing adoption of dialysis treatment among patient population as well as strong foothold of key industry players in the U.S. will further favor business growth.

Some of the notable players operating in dialysis market include Asahi Kasei Corporation, B. Braun Melsungen, Baxter International, Fresenius Medical Care, JMS, Kawasumi Laboratories, Medtronic, Nikkiso, Nipro, Toray, DaVita, U.S. Renal Care, Satellite Healthcare and Rogosin Institute. Industry players are majorly focusing on inorganic strategies such as acquisitions, partnership, merger and new product launch to enhance their existing product portfolio and strengthen position in the market.

Report Content
Chapter 1. Methodology
1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. Dialysis industry 3600 synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Type trends
2.1.3. Product and services trends
2.1.4. End-use trends
2.1.5. Regional trends
Chapter 3. Dialysis Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 - 2024
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Rising number of end stage renal diseases (ESRD) patients globally
3.3.1.2. Increasing incidence of diabetes in developing economies
3.3.1.3. Shortage of donor kidneys worldwide
3.3.1.4. Favorable reimbursement scenario available for dialysis treatment in North America
3.3.1.5. R&D investments in developed as well as developing countries
3.3.2. Industry pitfalls and challenges
3.3.2.1. Product recalls
3.3.2.2. Complications in the treatment
3.4. Growth potential analysis
3.4.1. By type
3.4.2. By product and services
3.4.3. By end-use
3.5. Porter’s analysis
3.6. Competitive landscape, 2017
3.6.1. Strategy dashboard
3.7. PESTEL analysis

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Blog : http://news-researchers.com/

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

This release was published on openPR.